drugset / Trial / NCT03687021

Clinical Study on Endometrial Receptivity

NCT03687021

Phase 0 Unknown 35 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupDouble-blindDiagnostic

Summary

to explore the differential expression of miRNA in the implantation window of patients with endometriosis and the time of progesterone and route of administration on planting window

Timeline

Start
2018-10-10
Primary completion
2018-10-10
Completion
2018-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 20 mg Intramuscular
Subject Progesterone Other / unclassified 40 mg Intramuscular
Subject Progesterone Other / unclassified 90 mg Intramuscular

Indications

No indication recorded.